Meanwhile, in Huntington’s disease (HD), PFN1 maintains huntingtin (Htt) in a soluble state and reduces its aggregation and toxicity by interacting with proline-rich domains (PRD) of Htt (14, 15, 16). This evidence concerns the gene HTT and Huntington disease.